Crossmark

Weak HIF-1alpha expression indicates poor prognosis in resectable pancreatic ductal adenocarcinoma

Crossref DOI link: https://doi.org/10.1186/s12957-018-1432-4

Published Online: 2018-07-04

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Leppänen, Joni https://orcid.org/0000-0002-6360-021X
Helminen, Olli

Huhta, Heikki

Kauppila, Joonas H.

Isohookana, Joel

Haapasaari, Kirsi-Maria

Parkkila, Seppo

Saarnio, Juha

Lehenkari, Petri P.

Karttunen, Tuomo J.
Funding

Funding for this research was provided by:

Pohjois-Pohjanmaan Rahasto

Suomen Lääketieteen Säätiö

Emil Aaltosen Säätiö

Sigrid Juséliuksen Säätiö

Thelma Mäkikyrö Foundation

Orionin Tutkimussäätiö

Päivikki ja Sakari Sohlbergin Säätiö
License Information

Text and Data Mining valid from 2018-07-04
More Information

Article History

Received: 8 February 2018

Accepted: 26 June 2018

First Online: 4 July 2018

Ethics approval and consent to participate

: The use of the samples and the data inquiry were approved by the Oulu University Hospital Ethics Committee and by the National Authority for Medicolegal Affairs (VALVIRA); (EETTMK:81/2008).

: Not applicable

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.